Sign Up Today and Learn More About METiS Pharmaceuticals Stock
Invest in or calculate the value of your shares in METiS Pharmaceuticals or other pre-IPO companies through EquityZen's platform.
METiS Pharmaceuticals Stock (METP)
METiS Pharmaceuticals is the world's first AI-driven drug formulation company.
About METiS Pharmaceuticals Stock
Founded
2020
Industries
Software, Artificial Intelligence, Data and Analytics
METiS Pharmaceuticals Press Mentions
Stay in the know about the latest news on METiS Pharmaceuticals
CICC Capital leads METiS's Series C round and 25 other Greater China deals worth $420m
dealstreetasia • Jun 25, 2024
METiS Pharmaceuticals Management
Leadership team at METiS Pharmaceuticals
Co-Founder & Chief Executive Officer
Chris Lai
Join now and verify your accreditation status to gain access to:
- METiS Pharmaceuticals current valuation
- METiS Pharmaceuticals stock price
- Available deals in METiS Pharmaceuticals and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading METiS Pharmaceuticals Stock
How to invest in METiS Pharmaceuticals stock?
Accredited investors can buy pre-IPO stock in companies like METiS Pharmaceuticals through EquityZen funds. These investments are made available by existing METiS Pharmaceuticals shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell METiS Pharmaceuticals stock?
Shareholders can sell their METiS Pharmaceuticals stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
